The burden of blood cancer on the world’s male population is set to increase in the next 25 years, according to a new analysis.
The increased rates will partly be driven by the ageing population, according to the study in published in the journal Cancer. Deaths from cancer – including lymphoma, myeloma and leukaemia – will more than double among men aged 65 and older, the study found.
However, the researchers also predict small increases in numbers of deaths amongst men of working age – with a 42% increase in myeloma deaths reflecting a similar increase in the number of cases.
The findings come from a global analysis of trends in 30 cancers amongst the male population. The biggest increases in cancer deaths are expected to be in Africa and the Eastern Mediterranean region of the World Health Organisation, they report.
The researchers say that men are less likely than women to take part in prevention activities and will continue to face increased exposure to risk factors such as smoking, alcohol consumption and occupational risks. They say the trends could be reduced by improved access to prevention, screening, diagnosis and treatment.
Lead researcher Habtamu Mellie Bizuayehu, of the University of Queensland, Australia, said: “A national and international collaboration, as well as a coordinated multisectoral approach, are essential to improve current cancer outcomes and to reverse the anticipated rise in cancer burden by 2050.
“Implementing and expanding universal health coverage and expanding health infrastructure and establishing publicly funded medical schools and scholarships for training medical and public health staff can improve cancer care and equity.”
Source:
Bizuayehu HM, Dadi AF, Ahmed KY, Tegegne TK, Hassen TA, Kibret GD, Ketema DB, Bore MG, Thapa S, Odo DB, Kassa ZY, Shifti DM, Amsalu E, Sarich P, Venchiarutti RL, Melaku YA, Kibret KT, Habte A, Mefsin YM, Seid A, Belachew SA. (2024) “Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population-based estimates.” Cancer, 12 August 2024, doi: 10.1002/cncr.35458
Link: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35458
Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.
News service provided by Englemed News.